IP Library Granted Patent US 6,933,121
Granted Patent B2
US 6,933,121 · App. 10/396,315 · Granted Aug 23, 2005

Use of predetermined nucleotides having altered base pairing characteristics in the amplification of nucleic acid molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,933,121
App. No.
10/396,315
Granted
Aug 23, 2005
Kind
B2
Abstract

The present invention provides improved methods for amplifying a nucleic acid molecule. More specifically, the invention provides methods for nucleic acid amplification which use primers having equivalent priming efficiency.

Claims (52)

1. A kit for amplifying a nucleic acid, said kit comprising:

a set of first and second amplification primers which exhibit a decreased difference between their T m s with respect to each other when hybridized to a template, wherein one or both of said primers is delectably labeled, and wherein said primers are contained in close compartmentalization.

2. The kit of claim 1 , wherein said primers are contained separately from each other.

3. The kit of claim 1 , further comprising a nucleic acid polymerase.

4. The kit of claim 3 , wherein said polymerase is contained separately from one or both of said primers.

5. The kit of claim 4 , wherein said polymerase is a DNA polymerase.

6. The kit of claim 4 , wherein said polymerase is a reverse transcriptase.

7. The kit of claim 1 , wherein said primers have equalized T m s.

8. The kit of claim 1 , wherein one or both of said primers comprises a nucleotide having an altered base pairing characteristic.

9. The kit of claim 1 , wherein said detectable label is an enzymatic label, radioisotopic label, fluorescent label, chemical label, or modified base.

10. The kit of claim 9 , wherein said detectable label is a fluorescent label.

11. The kit of claim 1 , wherein one or both of said primers comprises a poly-G, poly-A, poly-T, or poly-C sequence.

12. A method of making amplification primers, said method comprising:

synthesizing a set of first and second amplification primers which exhibit a decreased difference between their T m s with respect to each other when hybridized to a template, wherein one or both of said primers is detectable labeled.

13. The method of claim 12 , wherein said primers have equalized T m s.

14. The method of claim 12 , wherein one or both of said primers comprises a nucleotide having an altered base pairing characteristic.

15. The method of claim 12 , wherein said detectable label is an enzymatic label, radioisotopic label, fluorescent label, chemical label, or modified base.

16. The method of claim 15 , wherein said detectable label is a fluorescent label.

17. The method of claim 12 , wherein one or both of said primers comprises a poly-G, poly-A, poly-T, or poly-C sequence.

18. A method for amplifying a nucleic acid, said method comprising:

amplifying the nucleic acid using a set of first and second amplification primers which exhibit a decreased difference between their T m s with respect to each other when hybridized to a template, wherein one or both of said primers is detectable labeled.

19. The method of claim 18 , wherein said primers have equalized T m s.

20. The method of claim 18 , wherein one or both of said primers comprises a nucleotide having an altered base pairing characteristic.

21. The method of claim 18 , wherein said detectable label is an enzymatic label, radioisotopic label, fluorescent label, chemical label, or modified base.

22. The method of claim 21 , wherein said detectable label is a fluorescent label.

23. The method of claim 18 , wherein one or both of said primers comprises a poly-G, poly-A, poly-T, or poly-C sequence.

24. The method of claim 18 , wherein said nucleic acid is DNA.

25. The method of claim 18 , wherein said nucleic acid is RNA.

26. The method of claim 18 , wherein said nucleic acid is polyadenylated at its 3′ end, and wherein one of said primers contains poly-T.

27. The method of claim 18 , wherein said nucleic acid, copy thereof, or complementary copy thereof has been extended to contain a 3′ sequence to which one of said primers can hybridize.

28. An amplification mixture, said mixture comprising:

a set of first and second amplification primers which exhibit a decreased difference between their T m s with respect to each other when hybridized to a template, wherein one or both of said primers is detectable labeled.

29. The mixture of claim 28 , further comprising a nucleic acid polymerase.

30. The mixture of claim 29 , wherein said polymerase is a DNA polymerase.

31. The mixture of claim 29 , wherein said polymerase is a reverse transcriptase.

32. The mixture of claim 28 , wherein said primers have equalized T m s.

33. The mixture of claim 28 , wherein one or both of said primers comprises a nucleotide having an altered base pairing characteristic.

34. The mixture of claim 28 , wherein said detectable label is an enzymatic label, radioisotopic label, fluorescent label, chemical label, or modified base.

35. The mixture of claim 34 , wherein said detectable label is a fluorescent label.

36. The mixture of claim 28 , wherein one or both of said primers comprises a poly-G, poly-A, poly-T, or poly-C sequence.

37. The mixture of claim 28 , further comprising a nucleic acid template.

38. The mixture of claim 37 , wherein said template is DNA.

39. The mixture of claim 37 , wherein said template is RNA.

40. The mixture of claim 37 , wherein said template is polyadenylated at its 3′ end, and wherein one of said primers contains poly-T.

41. The mixture of claim 37 , wherein said template, copy thereof, or complementary copy thereof has been extended to contain a 3′ sequence to which one of said primers can hybridize.

42. A method for selecting amplification primers, said method comprising:

selecting a set of first and second amplification primers which exhibit a decreased difference between their T m s with respect to each other when hybridized to a template, wherein one or both of said primers is detectable labeled.

43. The method of claim 42 , wherein said primers have equalized T m s.

44. The method of claim 42 , wherein one or both of said primers comprises a nucleotide having an altered base pairing characteristic.

45. The method of claim 42 , wherein said detectable label is an enzymatic label, radioisotopic label, fluorescent label, chemical label, or modified base.

46. The method of claim 45 , wherein said detectable label is a fluorescent label.

47. The method of claim 42 , wherein one or both of said primers comprises a poly-G, poly-A, poly-T, or poly-C sequence.

Assignments (3)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
CHANGE OF NAME Recorded Jan 29, 2009
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 022162/0821 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →